Concepedia
Statistics
Publications
28
Citations
3.4K
H-Index
22
Active since
2000
Affiliations
Pfizer (United States)(Current)
Utah State University
University of Alberta
Scripps Research Institute
University of Maryland, Baltimore
Matthew R. Reese is an author at Pfizer (United States) specializing in drug discovery, pharmacology, and medicinal chemistry.
Publications per year
2000–2025
An oral SARS-CoV-2 M <sup>pro</sup> inhibitor clinical candidate for the treatment of COVID-19
Dafydd R. Owen, Charlotte Allerton, Annaliesa S. Anderson et al. · Science · 2021 · 1.9K citations · Full text
Medicine, Infectious Diseases, Pharmacology +13
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
Britton Boras, Rhys Jones, Brandon J. Anson et al. · Nature Communications · 2021 · 296 citations · Full text
Pharmacy, Infectious Diseases, Pharmacology +15
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19
Britton Boras, Rhys Jones, Brandon J. Anson et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 159 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
Sulfonamide Synthesis via Calcium Triflimide Activation of Sulfonyl Fluorides
Paramita Mukherjee, Cristian P. Woroch, Leah Cleary et al. · Organic Letters · 2018 · 123 citations · Full text
Natural Sciences, Chemistry, Inorganic Chemistry +5
Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for Schizophrenia
Amy B. Dounay, Marie Anderson, Bruce M. Bechle et al. · ACS Medicinal Chemistry Letters · 2012 · 90 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +13
1–5 of 28